Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cera Nieto
Observed names:
Cera M Nieto,
Cera M. Nieto
Institutions:
University of Colorado Anschutz,
University of Colorado Denver
Observed institutions:
National Institutes of Health,
Yale University,
University of Colorado Cancer Center,
National Cancer Institute,
University of Colorado Anschutz,
University of Colorado Denver
show all 6
ORCID:
0000-0001-8835-6236
Observed ORCID:
0000-0001-8835-6236
OpenAlex ID:
A5063237176
Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells
2020
·
Karina E. Gomez
, FangLong Wu
, et al.
·
Cancer Research
·
177
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2
2016
·
Stephen B. Keysar
, Phuong N. Le
, et al.
·
JNCI Journal of the National Cancer Institute
·
124
Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer
2015
·
Lindsey Ulkus Rodrigues
, Leah Rider
, et al.
·
Cancer Research
·
95
Wnt signaling dynamics in head and neck squamous cell cancer tumor‐stroma interactions
2018
·
Phuong N. Le
, Stephen B. Keysar
, et al.
·
Molecular Carcinogenesis
·
74
Influence of stromal–epithelial interactions on androgen action
2014
·
Cera M Nieto
, Leah C Rider
, et al.
·
Endocrine Related Cancer
·
43
MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1
2021
·
Lauren K. Jillson
, Leah C. Rider
, et al.
·
Molecular Cancer Research
·
25
Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer
2018
·
John J. Morton
, Stephen B. Keysar
, et al.
·
Molecular Carcinogenesis
·
24
Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma
2020
·
Stephen B. Keysar
, Nathan Gomes
, et al.
·
Cancer Research
·
21
Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function
2019
·
Farshad N. Chowdhury
, Julie Reisinger
, et al.
·
Oral Oncology
·
18
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma
2023
·
Cera Nieto
, Bettina Miller
, et al.
·
JNCI Journal of the National Cancer Institute
·
16
PDF
Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft
2020
·
J. Jason Morton
, Nathaniel Alzofon
, et al.
·
Molecular Cancer Research
·
12
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts
2025
·
J. Jason Morton
, Stephan A. Ramos
, et al.
·
Cancer Research Communications
·
4
Improved Methods for the Stable Generation of Human Papillomavirus‐Driven Head and Neck Cancer Cell Lines
2025
·
Phuong N. Le
, Stephen B. Keysar
, et al.
·
Molecular Carcinogenesis
·
1
PDF
Data from Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma
2023
·
Stephen B. Keysar
, Nathan Gomes
, et al.
·
1
Figure 3 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Figure 3 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Figure 1 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Table 1 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Data from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Figure 2 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Figure 1 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Figure 4 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Table 2 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Table 1 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Supplemental Figure 2 from Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes
2026
·
Alice N. Weaver
, Stephen B. Keysar
, et al.
Show more works
View as search
Works count:
53
Citation count:
635
H-index:
11
I10-index:
11
Year
Topic
Type